Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...
A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...
The Government has set out how it intends to transform cancer detection and treatment in a new 10-year plan.
Swedish researchers discover a blood test that can detect Parkinson's disease up to 20 years before symptoms appear, offering ...
A potential blood test can distinguish ME/chronic fatigue syndrome with great accuracy, after years of medical uncertainty.
More than 1.1 million Americans live with the degenerative brain condition, which can trigger debilitating tremors and effect memory ...
A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.
During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results